HopeStage
Back to all studies
Not recruitingISRCTN18035062

A feasibility study to evaluate a digital intervention for treating unipolar depression in adults

Research studyAges 18–65Germany
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Germany
Compensation
Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Elona Health GmbH
Sponsor type
Other organization
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
Germany
Age range
From 18 Years to 65 Years
Official registry ID
ISRCTN18035062
Official title
Show the full official title

A feasibility study to evaluate a digital intervention for treating unipolar depression in adults

Questions about this study?

The HopeStage team will email you.

Loading the security check...

Recruitment & locations

Not recruiting

Germany

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Elona Health GmbH.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me